Oppenheimer analyst Ken Wong lowered the firm’s price target on Bill (BILL) to $90 from $110 and keeps an Outperform rating on the shares. The ...

Oppenheimer analyst Jason Helfstein increased the price target for Amazon.com (NASDAQ:AMZN) to $260, up from the previous $230, while maintaining an Outperform rating on the stock. The adjustment ...

AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.

If you have been looking for Small Cap Growth funds, a place to start could be Oppenheimer Discovery Y (ODIYX). ODIYX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various ...

Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...